4893 items matching your search terms.

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board

Kao, S. C. Vardy, J. Chatfield, M. Corte, P. Pavlakis, N. Clarke, C. van Zandwijk, N. Clarke, S.
CLINICAL LUNG CANCER, 2013     DOI:10.1016/j.cllc.2012.03.011

Health-related quality of life and inflammatory markers in malignant pleural mesothelioma

Kao, S.C. Vardy, J. Harvie, R. Chatfield, M. van Zandwijk, N. Clarke, S. Pavlakis, N.

The rising cost of anti-cancer drugs in Australia

Karikios, D Schofield, D Salkeld, G Mann, K Trotman, J Stockler, M

The importance of glucose and lipid control in retinopathy

Keech, AC

Lipid lowering strategies in diabetes

Keech, A

Prognostic tool with iPad application

Kiely, B

Prognostic significance, accuracy and usefulness of oncologists’ estimates of survival time for patients starting first line chemotherapy for advanced non-small cell lung cancer

Kiely, BE Veillard, AS Davidson, JA Trinkaus, ME Briscoe, KP Hughes, BGM Begbie, S Pavlakis, N Millward, M Boyer, M Brown, C Muljadi, N Coskinas, X Stockler, MR

Prognostic significance, accuracy and usefulness of oncologists estimates of survival time for patients starting first line chemotherapy for advanced non-small cell lung cancer

Kiely, BE Veillard, AS Davidson, JA Trinkaus, ME Briscoe, P Hughes, BGM Begbie, S Pavlakis, N Millward, M Boyer, M Brown, C Muljadi, N Coskinas, X Stockler, M

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates

Kiely, B. E. Martin, A. J. Tattersall, M. H. Nowak, A. K. Goldstein, D. Wilcken, N. R. Wyld, D. K. Abdi, E. A. Glasgow, A. Beale, P. J. Jefford, M. Glare, P. A. Stockler, M. R.
JOURNAL OF CLINICAL ONCOLOGY, 2013     DOI:10.1200/JCO.2012.44.7821

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience

Kiely, B.E. McCaughan, G. Christodoulou, S. Beale, P.J. Grimison, P. Trotman, J. Tattersall, M.H. Stockler, M.R.
SUPPORTIVE CARE IN CANCER, 2013     DOI:10.1007/s00520-012-1526-4

Activity and reporting characteristics of clinical practice guideline implementation trials registered on the Australian New Zealand Clinical Trials Registry

Ko, H Hunter, K Askie, L

Comparative efficacy of a team-led treatment protocol for the management of renal anaemia

Kotwal, S. S. Lan, P. MacLeod, A. Jardine, M. Snelling, P. Craig, J. Cass, A. Gallagher, M.
NEPHROLOGY (CARLTON), 2013     DOI:10.1111/nep.12144

Imatinib PKPD relationship: results from an ongoing study

Kumar, SS Kirkpatrick, CM Mann, KP Ray, JE Graham, GG Williams, KM Day, RO Desai, J

Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: results of the ICON6 trial

Ledermann, JA Perren, TJ Raja, FA Embleton, A Rustin, GJS Jayson, G Kaye, SB Swart, AM Vaughan, M Hirte, H on behalf of the ICON6 Collaborators,

Prognostic significance of quality-of-life scores in early stage and relapsed breast cancer: results from seven randomized trials of the International Breast Cancer Study Group

Lee, CK Coates, A Hudson, M Ribi, K Bernhard, J